Minimal change disease relapse following SARS-CoV-2 mRNA vaccine

Detalles Bibliográficos
Autores principales: Kervella, Delphine, Jacquemont, Lola, Chapelet-Debout, Agnès, Deltombe, Clément, Ville, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098029/
https://www.ncbi.nlm.nih.gov/pubmed/33964312
http://dx.doi.org/10.1016/j.kint.2021.04.033
_version_ 1783688428721799168
author Kervella, Delphine
Jacquemont, Lola
Chapelet-Debout, Agnès
Deltombe, Clément
Ville, Simon
author_facet Kervella, Delphine
Jacquemont, Lola
Chapelet-Debout, Agnès
Deltombe, Clément
Ville, Simon
author_sort Kervella, Delphine
collection PubMed
description
format Online
Article
Text
id pubmed-8098029
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-80980292021-05-05 Minimal change disease relapse following SARS-CoV-2 mRNA vaccine Kervella, Delphine Jacquemont, Lola Chapelet-Debout, Agnès Deltombe, Clément Ville, Simon Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-08 2021-05-05 /pmc/articles/PMC8098029/ /pubmed/33964312 http://dx.doi.org/10.1016/j.kint.2021.04.033 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Kervella, Delphine
Jacquemont, Lola
Chapelet-Debout, Agnès
Deltombe, Clément
Ville, Simon
Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
title Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
title_full Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
title_fullStr Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
title_full_unstemmed Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
title_short Minimal change disease relapse following SARS-CoV-2 mRNA vaccine
title_sort minimal change disease relapse following sars-cov-2 mrna vaccine
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098029/
https://www.ncbi.nlm.nih.gov/pubmed/33964312
http://dx.doi.org/10.1016/j.kint.2021.04.033
work_keys_str_mv AT kervelladelphine minimalchangediseaserelapsefollowingsarscov2mrnavaccine
AT jacquemontlola minimalchangediseaserelapsefollowingsarscov2mrnavaccine
AT chapeletdeboutagnes minimalchangediseaserelapsefollowingsarscov2mrnavaccine
AT deltombeclement minimalchangediseaserelapsefollowingsarscov2mrnavaccine
AT villesimon minimalchangediseaserelapsefollowingsarscov2mrnavaccine

Ejemplares similares